Detalhe da pesquisa
1.
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
PLoS Pathog
; 17(9): e1009878, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34473805
2.
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches.
New Microbiol
; 45(3): 199-209, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920875
3.
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.
J Med Virol
; 93(4): 2160-2167, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064340
4.
Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
J Virol
; 93(11)2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867302
5.
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.
Gut
; 65(3): 512-23, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25661083
6.
The Question of HIV Vaccine: Why Is a Solution Not Yet Available?
J Immunol Res
; 2024: 2147912, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38628675
7.
The initial interplay between HIV and mucosal innate immunity.
Front Immunol
; 14: 1104423, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36798134
8.
HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role.
Clin Dev Immunol
; 2012: 705013, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22690241
9.
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2.
Viruses
; 14(6)2022 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35746703
10.
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials.
Emerg Microbes Infect
; 10(1): 206-210, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33399524
11.
Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy.
Viruses
; 13(8)2021 07 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452380
12.
Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein.
J Virol
; 82(2): 1047-52, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17989176
13.
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia.
Autoimmun Rev
; 7(6): 468-72, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18558364
14.
A Biologically-validated HCV E1E2 Heterodimer Structural Model.
Sci Rep
; 7(1): 214, 2017 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28303031
15.
Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge.
Antiviral Res
; 143: 48-61, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28396205
16.
New Insights into Immune-Based Diagnosis, Therapy and Prophylaxis for Infectious Diseases 2020.
J Immunol Res
; 2021: 9767464, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35005035
17.
Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases.
Front Immunol
; 11: 1670, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32849578
18.
Next Generation Vaccines for Infectious Diseases.
J Immunol Res
; 2019: 5890962, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31183388
19.
New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.
J Immunol Res
; 2017: 3104719, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28758132
20.
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference.
Antiviral Res
; 96(1): 82-9, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22898087